DDR2 and ovarian cancer: Furthermore, discoidin domain receptor tyrosine kinase 2 (DDR2) is upregulated in recurrent breast tumor cells, with sensitivity to ferroptosis enhanced by YAP/TAZ activation, which is unknown in ovarian cancer (Lin et al., 2021).